HLK Financial Statements From 2010 to 2025
| AMHD Stock | USD 0.0002 0.00 0.00% |
Check HLK Biotech financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HLK Biotech's main balance sheet or income statement drivers, such as , as well as many indicators such as . HLK financial statements analysis is a perfect complement when working with HLK Biotech Valuation or Volatility modules.
HLK |
HLK Biotech Holding Company Net Income Analysis
HLK Biotech's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current HLK Biotech Net Income | (3.77 K) |
Most of HLK Biotech's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, HLK Biotech Holding is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Based on the recorded statements, HLK Biotech Holding reported net income of (3,769). This is 100.0% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The net income for all United States stocks is 100.0% higher than that of the company.
HLK Biotech Holding Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HLK Biotech's current stock value. Our valuation model uses many indicators to compare HLK Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HLK Biotech competition to find correlations between indicators driving HLK Biotech's intrinsic value. More Info.HLK Biotech Holding is number one stock in return on asset category among its peers. It is rated fifth in revenue category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HLK Biotech's earnings, one of the primary drivers of an investment's value.About HLK Biotech Financial Statements
HLK Biotech stakeholders use historical fundamental indicators, such as HLK Biotech's revenue or net income, to determine how well the company is positioned to perform in the future. Although HLK Biotech investors may analyze each financial statement separately, they are all interrelated. For example, changes in HLK Biotech's assets and liabilities are reflected in the revenues and expenses on HLK Biotech's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in HLK Biotech Holding. Please read more on our technical analysis and fundamental analysis pages.
HLK Biotech Holding Group, Inc., through its subsidiaries, produces and sells biodiesel. HLK Biotech Holding Group, Inc. is headquartered in Norfolk, Virginia. Amelot Holdings is traded on OTC Exchange in the United States.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in HLK Pink Sheet
HLK Biotech financial ratios help investors to determine whether HLK Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in HLK with respect to the benefits of owning HLK Biotech security.